Dr. Sukhjit “Sarge” Takhar, co-founder and CMO of PrimaryMD, emphasizes that longevity medicine adds proactive care to traditional primary care. Instead of focusing solely on illness, it emphasizes cardiometabolic fitness, sleep, diet, and prevention strategies. While promising, Takhar notes that data supporting many interventions remains limited.
Risks and Misconceptions
The rise of commercial longevity products has led to misconceptions and overconfidence. Takhar warns that overreliance on preliminary research, wearable metrics, or supplements can be harmful. “People often read online posts and confuse signals with outcomes or mouse studies with human effects,” he explains. Overselling experimental therapies without clinical oversight is a common risk.
Integrating Technology Thoughtfully
Takhar incorporates technological tools selectively, such as whole-body MRI and whole-genome testing. While MRIs can detect potentially life-threatening conditions, they are not a replacement for standard screenings like pap smears or colonoscopies. Genomic testing, including polygenic risk scores and BRCA mutation screening, helps tailor preventive strategies and personalized care.
Practical Focus for Longevity
Despite technological allure, Takhar advises patients to prioritize foundational health behaviors: balanced nutrition, regular exercise, sufficient sleep, and social connections. Misuse of hormones or experimental peptides may yield short-term benefits but long-term risks. Evidence-based clinical guidance remains essential for safe, effective longevity interventions.
The Bigger Picture
Longevity medicine’s popularity reflects society’s desire for optimized health, but without qualified oversight, the public risks chasing trends rather than sustainable, science-backed strategies. Takhar’s approach integrates primary care with evidence-based longevity practices, ensuring patient safety while exploring lifespan extension responsibly.